These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 35389352)

  • 21. Practice of Monitoring Cisplatin-Induced Ototoxicity by Audiology, ENT, and Oncology Specialists: A Survey-Based Study in a Single Italian Medical Center.
    Gambacorta V; Orzan E; Faralli M; Gullà M; Lapenna R; Baietta I; De Angelis V; Ricci G
    Audiol Res; 2023 Oct; 13(5):779-790. PubMed ID: 37887850
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recommendations for Age-Appropriate Testing, Timing, and Frequency of Audiologic Monitoring During Childhood Cancer Treatment: An International Society of Paediatric Oncology Supportive Care Consensus Report.
    Meijer AJM; van den Heuvel-Eibrink MM; Brooks B; Am Zehnhoff-Dinnesen AG; Knight KR; Freyer DR; Chang KW; Hero B; Papadakis V; Frazier AL; Blattmann C; Windsor R; Morland B; Bouffet E; Rutkowski S; Tytgat GAM; Geller JI; Hunter LL; Sung L; Calaminus G; Carleton BC; Helleman HW; Foster JH; Kruger M; Cohn RJ; Landier W; van Grotel M; Brock PR; Hoetink AE; Rajput KM;
    JAMA Oncol; 2021 Oct; 7(10):1550-1558. PubMed ID: 34383016
    [TBL] [Abstract][Full Text] [Related]  

  • 23. High-frequency audiometry reveals high prevalence of aminoglycoside ototoxicity in children with cystic fibrosis.
    Al-Malky G; Dawson SJ; Sirimanna T; Bagkeris E; Suri R
    J Cyst Fibros; 2015 Mar; 14(2):248-54. PubMed ID: 25127922
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Usefulness of current candidate genetic markers to identify childhood cancer patients at risk for platinum-induced ototoxicity: Results of the European PanCareLIFE cohort study.
    Langer T; Clemens E; Broer L; Maier L; Uitterlinden AG; de Vries ACH; van Grotel M; Pluijm SFM; Binder H; Mayer B; von dem Knesebeck A; Byrne J; van Dulmen-den Broeder E; Crocco M; Grabow D; Kaatsch P; Kaiser M; Spix C; Kenborg L; Winther JF; Rechnitzer C; Hasle H; Kepak T; van der Kooi AF; Kremer LC; Kruseova J; Bielack S; Sorg B; Hecker-Nolting S; Kuehni CE; Ansari M; Kompis M; van der Pal H; Parfitt R; Deuster D; Matulat P; Tillmanns A; Tissing WJE; Beck JD; Elsner S; Am Zehnhoff-Dinnesen A; van den Heuvel-Eibrink MM; Zolk O;
    Eur J Cancer; 2020 Oct; 138():212-224. PubMed ID: 32905960
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Baseline audiological profiling of South African females with cervical cancer: an important attribute for assessing cisplatin-associated ototoxicity.
    Paken J; Govender CD; Pillay M; Ayele BT; Sewram V
    BMC Womens Health; 2021 Apr; 21(1):164. PubMed ID: 33879158
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Virtualized clinical studies to assess the natural history and impact of gut microbiome modulation in non-hospitalized patients with mild to moderate COVID-19 a randomized, open-label, prospective study with a parallel group study evaluating the physiologic effects of KB109 on gut microbiota structure and function: a structured summary of a study protocol for a randomized controlled study.
    Haran JP; Pinero JC; Zheng Y; Palma NA; Wingertzahn M
    Trials; 2021 Apr; 22(1):245. PubMed ID: 33810796
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The current state of ototoxicity monitoring in New Zealand.
    Steffens L; Venter K; O'Beirne GA; Kelly-Campbell R; Gibbs D; Bird P
    N Z Med J; 2014 Jul; 127(1398):84-97. PubMed ID: 25146864
    [TBL] [Abstract][Full Text] [Related]  

  • 28. An Ototoxicity Grading System Within a Mobile App (OtoCalc) for a Resource-Limited Setting to Guide Grading and Management of Drug-Induced Hearing Loss in Patients With Drug-Resistant Tuberculosis: Prospective, Cross-Sectional Case Series.
    Hollander C; Joubert K; Schellack N
    JMIR Mhealth Uhealth; 2020 Jan; 8(1):e14036. PubMed ID: 31934875
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effectiveness of Individual Feedback and Coaching on Shared Decision-making Consultations in Oncology Care: Protocol for a Randomized Clinical Trial.
    van Veenendaal H; Peters LJ; Ubbink DT; Stubenrouch FE; Stiggelbout AM; Brand PL; Vreugdenhil G; Hilders CG
    JMIR Res Protoc; 2022 Apr; 11(4):e35543. PubMed ID: 35383572
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of risk factors for cisplatin-induced ototoxicity in patients with testicular cancer.
    Bokemeyer C; Berger CC; Hartmann JT; Kollmannsberger C; Schmoll HJ; Kuczyk MA; Kanz L
    Br J Cancer; 1998 Apr; 77(8):1355-62. PubMed ID: 9579846
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Recommendations for ototoxicity surveillance for childhood, adolescent, and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group in collaboration with the PanCare Consortium.
    Clemens E; van den Heuvel-Eibrink MM; Mulder RL; Kremer LCM; Hudson MM; Skinner R; Constine LS; Bass JK; Kuehni CE; Langer T; van Dalen EC; Bardi E; Bonne NX; Brock PR; Brooks B; Carleton B; Caron E; Chang KW; Johnston K; Knight K; Nathan PC; Orgel E; Prasad PK; Rottenberg J; Scheinemann K; de Vries ACH; Walwyn T; Weiss A; Am Zehnhoff-Dinnesen A; Cohn RJ; Landier W;
    Lancet Oncol; 2019 Jan; 20(1):e29-e41. PubMed ID: 30614474
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Concordance between the chang and the International Society of Pediatric Oncology (SIOP) ototoxicity grading scales in patients treated with cisplatin for medulloblastoma.
    Bass JK; Huang J; Onar-Thomas A; Chang KW; Bhagat SP; Chintagumpala M; Bartels U; Gururangan S; Hassall T; Heath JA; McCowage G; Cohn RJ; Fisher MJ; Robinson G; Broniscer A; Gajjar A; Gurney JG
    Pediatr Blood Cancer; 2014 Apr; 61(4):601-5. PubMed ID: 24504791
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hearing Norton Sound: mixed methods protocol of a community randomised trial to address childhood hearing loss in rural Alaska.
    Emmett SD; Robler SK; Gallo JJ; Wang NY; Labrique A; Hofstetter P
    BMJ Open; 2019 Jan; 9(1):e023081. PubMed ID: 30674486
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Metabolic Syndrome Parameters, Determinants, and Biomarkers in Adult Survivors of Childhood Cancer: Protocol for the Dutch Childhood Cancer Survivor Study on Metabolic Syndrome (Dutch LATER METS).
    Pluimakers V; Fiocco M; van Atteveld J; Hobbelink M; Bresters D; Van Dulmen-den Broeder E; Van der Heiden-van der Loo M; Janssens GO; Kremer L; Loonen J; Louwerens M; Van der Pal H; Ronckers C; Van Santen H; Versluys B; De Vries A; Van den Heuvel-Eibrink M; Neggers S
    JMIR Res Protoc; 2021 Jan; 10(1):e21256. PubMed ID: 32750002
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial.
    Deckert A; Anders S; de Allegri M; Nguyen HT; Souares A; McMahon S; Boerner K; Meurer M; Herbst K; Sand M; Koeppel L; Siems T; Brugnara L; Brenner S; Burk R; Lou D; Kirrmaier D; Duan Y; Ovchinnikova S; Marx M; Kräusslich HG; Knop M; Bärnighausen T; Denkinger C
    Trials; 2021 Jan; 22(1):39. PubMed ID: 33419461
    [TBL] [Abstract][Full Text] [Related]  

  • 36. A Randomized Controlled Trial Using Automated Technology for Improving Ototoxicity Monitoring in VA Oncology Patients.
    Konrad-Martin D; O'Connell Bennett K; Garinis A; McMillan GP
    Am J Audiol; 2021 Oct; 30(3S):870-886. PubMed ID: 34582263
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A Web-Based Lifestyle Intervention Aimed at Improving Cognition in Patients With Cancer Returning to Work in an Outpatient Setting: Protocol for a Randomized Controlled Trial.
    Drijver AJ; Reijneveld JC; Wesselman LMP; Klein M
    JMIR Res Protoc; 2021 Apr; 10(4):e22670. PubMed ID: 33900201
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of a New Personalized Health Dashboard in Preventive Child Health Care: Protocol for a Mixed Methods Feasibility Randomized Controlled Trial.
    Weijers M; Feron F; van der Zwet J; Bastiaenen C
    JMIR Res Protoc; 2021 Mar; 10(3):e21942. PubMed ID: 33724191
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Diagnosing Preclinical Cardiac Dysfunction in Swiss Childhood Cancer Survivors: Protocol for a Single-Center Cohort Study.
    Schindera C; Kuehni CE; Pavlovic M; Haegler-Laube ES; Rhyner D; Waespe N; Roessler J; Suter T; von der Weid NX
    JMIR Res Protoc; 2020 Jun; 9(6):e17724. PubMed ID: 32269016
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hearing loss in children with brain tumors treated with cisplatin and carboplatin-based high-dose chemotherapy with autologous bone marrow rescue.
    Freilich RJ; Kraus DH; Budnick AS; Bayer LA; Finlay JL
    Med Pediatr Oncol; 1996 Feb; 26(2):95-100. PubMed ID: 8531860
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.